U.S. Patent 7774145 was awarded to DexCom, Inc. on 2010-08-10 and describes a “Transcutaneous analyte sensor.” This patent has been cited 249 times by other U.S. patents which places it in the top 500 cited patents since 2010 according to our law firm research, and makes it of the most innovative medical technology patents in the field of instruments. The abstract states:

The present invention relates generally to systems and methods for measuring an analyte in a host. More particularly, the present invention relates to systems and methods for transcutaneous measurement of glucose in a host. In some embodiments, a device is provided for monitoring glucose concentration in a host, including a continuous glucose sensor and an integrated receiver including a single point glucose monitor. In some embodiments, a computer system is provided that determines a rate of change of continuous analyte sensor data. Link: U.S. Patent 7774145

This patent was originally filed on 2006-01-18 which gives it a processing time of 1665 days, compared to an average processing time of 1177 in the field. DexCom, Inc. has 423 total patents. The first named inventor is James H. Brauker of Addison, IL. The primary examiner was Tung S Lau.

Select Patents monitors top medical technology patents and instruments patents which have been allowed and granted worldwide. If you would like legal advice regarding a patent or would like to file a patent go to https://selectpatents.wpengine.com/contact/